Siga Technologies (NASDAQ:SIGA) Posts Quarterly Earnings Results

Key Points

• Siga Technologies reported earnings of $0.49 earnings per share for the latest quarter, reflecting a return on equity of 25.21% and a net margin of 40.30%.
• The company's stock price is currently $6.60, with a market capitalization of $471.50 million and a price-to-earnings ratio of 9.85.
• Recently, Strs Ohio acquired a new stake in Siga Technologies, purchasing 30,200 shares valued at approximately $165,000, bringing institutional ownership to 55.40%.

Siga Technologies (NASDAQ:SIGA - Get Free Report) posted its earnings results on Tuesday. The company reported $0.49 earnings per share (EPS) for the quarter, Zacks reports. Siga Technologies had a return on equity of 40.52% and a net margin of 45.73%. The business had revenue of $81.12 million during the quarter.

Siga Technologies Price Performance

SIGA traded up $0.41 on Friday, reaching $8.96. The company's stock had a trading volume of 831,891 shares, compared to its average volume of 439,005. The stock has a market cap of $641.63 million, a price-to-earnings ratio of 7.93 and a beta of 0.94. Siga Technologies has a 1 year low of $4.95 and a 1 year high of $12.83. The business's 50 day moving average is $6.67 and its 200 day moving average is $6.13.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded Siga Technologies from a "hold" rating to a "strong-buy" rating in a research note on Saturday.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Siga Technologies stock. Jane Street Group LLC boosted its holdings in Siga Technologies Inc. (NASDAQ:SIGA - Free Report) by 138.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 114,147 shares of the company's stock after purchasing an additional 66,265 shares during the period. Jane Street Group LLC owned about 0.16% of Siga Technologies worth $626,000 at the end of the most recent reporting period. 55.40% of the stock is owned by institutional investors and hedge funds.

About Siga Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.